MapLight Therapeutics, Inc. (MPLT)

MapLight Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2024	Dec 31, 2023
Net Income	-92.43	-77.58	-55.71
Depreciation & Amortization	-0.84	-1.04	0.56
Share-Based Compensation	-	1.08	1.05
Other Operating Activities	-7.59	-1.28	2.1
Operating Cash Flow	-100.86	-78.82	-52.01
Capital Expenditures	-0.55	-0.77	-0.46
Change in Investments	-	-80.02	-
Investing Cash Flow	95.97	-80.79	-0.46
Share Issuance / Repurchase	-	120.25	104.57
Other Financing Activities	-0.41	-2.19	-
Financing Cash Flow	-0.41	118.06	104.57
Net Cash Flow	-5.3	-41.54	52.1
Free Cash Flow	-101.41	-79.59	-52.47

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).